The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000097:blood*; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D011188:Potassium / Q000652:urine; D012083:Renin / Q000097:blood*; D012504:Saralasin / Q000627:therapeutic use*; D012964:Sodium / Q000652:urine
D000804:Angiotensin II; D000450:Aldosterone; D012964:Sodium; D012083:Renin; D012504:Saralasin; D011188:Potassium